Abstract：
BACKGROUND:Preclinical evidence suggests that aspirin may inhibit lung cancer progression. In a large cohort of lung cancer patients, we investigated whether low-dose aspirin use was associated with a reduction in the risk of lung cancer-specific mortality. METHODS:We identified lung cancer patients from English cancer registries diagnosed between 1998 to 2009 from the National Cancer Data Repository. Medication usage was obtained from linkages to the UK Clinical Practice Research Datalink and lung cancer-specific deaths were identified from Office of National Statistics mortality data. Hazard ratios (HR) and 95 % confidence intervals (CI) for the association between low-dose aspirin use (before and after diagnosis) and risk of lung cancer-specific mortality were calculated using Cox regression models. RESULTS:A total of 14,735 lung cancer patients were identified during the study period. In analysis of 3,635 lung cancer patients, there was no suggestion of an association between low-dose aspirin use after diagnosis and cancer-specific mortality (adjusted HR=0.96, 95% CI: 0.85, 1.09). Similarly, no association was evident for low-dose aspirin use before diagnosis and cancer-specific mortality (adjusted HR=1.00, 95% CI: 0.95, 1.05). Associations were comparable by duration of use and for all-cause mortality. CONCLUSION:Overall, we found little evidence of a protective association between low-dose aspirin use and cancer-specific mortality in a large population-based lung cancer cohort.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Mc Menamin ÚC,Cardwell CR,Hughes CM,Murray LMdoi
10.1186/s12885-015-1910-9subject
Has Abstractpub_date
2015-11-17 00:00:00pages
911issn
1471-2407pii
10.1186/s12885-015-1910-9journal_volume
15pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Compared with World Health Organization-defined acute myeloid leukaemia (AML) not otherwise specified, patients with AML with myelodysplasia-related changes (AML-MRC) are generally older and more likely to have poor-risk cytogenetics, leading to poor response and prognosis. More than one-half of all older (≥...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-017-3803-6
更新日期：2017-12-14 00:00:00
abstract：BACKGROUND:Tamoxifen has dramatically reduced the recurrence and mortality rate of estrogen receptor positive breast cancer. However, the efficacy of tamoxifen varies between individuals and 40% of patients will have a recurrence despite adjuvant tamoxifen treatment. Factors that predict tamoxifen efficacy would be hel...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-612
更新日期：2013-12-28 00:00:00
abstract：BACKGROUND:Currently, there are three main surgical approaches for resectable esophageal cancer: open transthoracic esophagectomy (OTE), conventional minimally invasive esophagectomy (MIE) and robot-assisted esophagectomy (RAE). Previous studies had demonstrated the better short-term outcomes in MIE or RAE when compare...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-019-5799-6
更新日期：2019-06-21 00:00:00
abstract：BACKGROUND:The role of radiation therapy in addition to chemotherapy has not been well established in non-oligometastatic Stage IV non-small cell lung cancer (NSCLC). We aimed to investigate overall survival (OS) of non-oligometastatic Stage IV NSCLC treated with chemotherapy with concurrent radiation to the primary tu...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2952-3
更新日期：2016-11-21 00:00:00
abstract：BACKGROUND:The prognostic significance of FOXP3+ tumor-infiltrating lymphocytes (TILs) in patients with breast cancer remains controversial. The aims of our meta-analysis are to evaluate its association with clinicopathological characteristics and prognostic significance in patients with breast cancer. METHODS:PubMed,...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-015-1742-7
更新日期：2015-10-17 00:00:00
abstract：BACKGROUND:Limited clinical data on real-world practice patterns are available for patients with metastatic/relapsed soft tissue sarcomas (STS). The primary objective of this study was to evaluate treatment patterns in patients with metastatic/relapsed STS following failure of prior chemotherapy by examining data colle...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1182-4
更新日期：2015-03-25 00:00:00
abstract：BACKGROUND:To help design clinical trials of adjuvant bisphosphonate therapy for breast cancer, the temporal incidence of bone metastasis was investigated in a cohort of patients. We have tried to draw the criteria to use adjuvant bisphosphonate. METHODS:Consecutive breast cancer patients undergoing surgery between 19...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/1471-2407-10-381
更新日期：2010-07-21 00:00:00
abstract：BACKGROUND:Breast cancer places a heavy burden on the Australian healthcare system, but information about the actual number of women living with breast cancer and their current or future health service needs is limited. We used existing population-based data and innovative statistical methods to address this critical r...
journal_title：BMC cancer
pub_type： 历史文章,杂志文章
doi：10.1186/1471-2407-14-936
更新日期：2014-12-11 00:00:00
abstract：BACKGROUND:Systemic inflammation has been implicated in cancer development and progression. This study examined the best cutoff value of erythrocyte sedimentation rate (ESR) in diffuse large B-cell lymphoma (DLBCL) patients. METHODS:The relationship between ESR and clinical characteristics was analyzed in 182 DLBCL pa...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4914-4
更新日期：2018-10-19 00:00:00
abstract：BACKGROUND:Significant progress in treatment of metastatic castration resistant prostate cancer (mCRPC) has been made. Biomarkers to tailor therapy are scarce. To facilitate decision-making we evaluated dynamic changes of alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and prostate specific antigen (PSA) under ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2260-y
更新日期：2016-03-14 00:00:00
abstract：BACKGROUND:The purpose of this study was to identify the risk factors associated with fatal pulmonary hemorrhage (PH) in patients with locally advanced non-small cell lung cancer (NSCLC), treated with chemoradiotherapy. METHODS:The medical records of 583 patients with locally advanced NSCLC, who were treated with chem...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-27
更新日期：2012-01-20 00:00:00
abstract：BACKGROUND:Fos-related antigen 1 (FRA-1) is an immediate early gene encoding a member of AP-1 family of transcription factors involved in cell proliferation, differentiation, apoptosis, and other biological processes. fra-1 gene overexpression has an important role in the process of cellular transformation, and our pre...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-17
更新日期：2007-01-25 00:00:00
abstract：BACKGROUND:Catumaxomab, the first anti-EpCAM antibody, was approved in 2009 for the treatment of malignant ascites in cancer patients with EpCAM positive tumors. We consider this case of interest as treatment with catumaxomab not only prolonged the puncture-free interval but also showed a systemic effect in a patient w...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-618
更新日期：2013-12-31 00:00:00
abstract：BACKGROUND:Cytochrome P450 1B1 (CYP1B1) has been shown to be up-regulated in many types of cancer including renal cell carcinoma (RCC). Several reports have shown that CYP1B1 can influence the regulation of tumor development; however, its role in RCC has not been well investigated. The aim of the present study was to d...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1951-0
更新日期：2015-12-01 00:00:00
abstract：BACKGROUND:To compare the value of two dynamic contrast-enhanced Magnetic Resonance Images (DCE-MRI) reconstruction approaches, namely golden-angle radial sparse parallel (GRASP) and view-sharing with golden-angle radial profile (VS-GR) reconstruction, and evaluate their values in assessing response to neoadjuvant chem...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6247-3
更新日期：2019-10-24 00:00:00
abstract：BACKGROUND:Pseudomyogenic hemangioendothelioma (PMHE) is a rare endothelial neoplasm that involves the bones in only 14% of all cases. The optimal treatment strategy has not been established. We herein report a case of primary PMHE in which denosumab treatment showed activity in both imaging studies and the clinical ou...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6072-8
更新日期：2019-09-03 00:00:00
abstract：BACKGROUND:The aim of this study was to determine the safety and efficacy of fractionated stereotactic radiotherapy (SRT) in combination with systemic therapies (ST) for brain metastases (BM). METHODS:Ninety-nine patients (171 BM) received SRT and concurrent ST (group 1) and 95 patients (131 BM) received SRT alone wit...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07491-z
更新日期：2020-10-13 00:00:00
abstract：BACKGROUND:Increased hemostatic activity is common in many cancer types and often causes additional complications and even death. Circumstantial evidence suggests that tissue factor pathway inhibitor-1 (TFPI) plays a role in cancer development. We recently reported that downregulation of TFPI inhibited apoptosis in a b...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-357
更新日期：2011-08-17 00:00:00
abstract：BACKGROUND:The purpose of this review is to update previously published reviews on exercise programming in exercise trials in prostate cancer survivors. We evaluated: 1) the application of the principles of exercise training in prescribed programs; 2) the reporting of the components of the exercise prescription; and 3)...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5520-9
更新日期：2019-04-05 00:00:00
abstract：BACKGROUND:PRDM5 is an epigenetic regulator that has been recognized as an important tumour suppressor gene. Silencing of PRDM5 by promoter hypermethylation has been demonstrated in several cancer types and PRDM5 loss results in upregulation of the Wnt pathway and increased cellular proliferation. PRDM5 has not been ex...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1011-9
更新日期：2015-01-23 00:00:00
abstract：BACKGROUND:The incidence of papillary thyroid cancer (PTC) is markedly higher in women than men during the reproductive years. In vitro studies have suggested that estrogen may play an important role in the development and progression of PTC through estrogen receptors (ERs). This study aimed to investigate the expressi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-383
更新日期：2014-05-29 00:00:00
abstract：BACKGROUND:Perineural invasion (PNI) is correlated with adverse survival in several malignancies, but its significance in esophageal squamous cell carcinoma (ESCC) remains to be clearly defined. The objective of this study was to determine the association between PNI status and clinical outcomes. METHODS:We retrospect...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-313
更新日期：2014-05-05 00:00:00
abstract：BACKGROUND:Cigarette smoking is an established risk factor for bladder cancer. Epidemiological and biological data suggest that genetic polymorphisms in activating and detoxifying enzymes may play a role in determining an individual's susceptibility to bladder cancer in particular when in combination with specific envi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-239
更新日期：2006-10-06 00:00:00
abstract：BACKGROUND:Neoadjuvant chemotherapy (NAC) is one of the standard care regimens for patients with resectable early-stage breast cancer. It would be advantageous to determine the chemosensitivity of tumors before initiating NAC. One of the parameters potentially compromising such chemosensitivity would be a hypoxic micro...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-400
更新日期：2014-06-04 00:00:00
abstract：BACKGROUND:The aim of this study was to evaluate epigenetic status of cyclin A1 in human papillomavirus-associated cervical cancer. Y. Tokumaru et al., Cancer Res 64, 5982-7 (Sep 1, 2004)demonstrated in head and neck squamous-cell cancer an inverse correlation between cyclin A1 promoter hypermethylation and TP53 mutati...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-55
更新日期：2006-03-08 00:00:00
abstract：BACKGROUND:This study aimed to determine the efficacy and complications of intravitreal chemotherapy-assisted endoresection for refractory International Classification of Retinoblastoma (ICRB) group D retinoblastoma in monocular patients. METHODS:In this retrospective case series, intravitreal chemotherapy-assisted en...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07314-1
更新日期：2020-08-26 00:00:00
abstract：BACKGROUND:A universal hallmark of cancer cells is the change in their glycosylation phenotype. One of the most frequent alterations in the normal glycosylation pattern observed during carcinogenesis is the enhancement of α(1,6)linked fucose residues of glycoproteins, due to the up-regulation of the α(1,6)fucosyltransf...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-508
更新日期：2011-12-07 00:00:00
abstract：BACKGROUND:To assess metastatic breast cancer (MBC) patient psychological factors, perceptions, and comprehension of tumor genomic testing. METHODS:In a prospective, single institution, single-arm trial, patients with MBC underwent next-generation sequencing at study entry with sequencing results released at progressi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-06905-2
更新日期：2020-05-06 00:00:00
abstract：BACKGROUND:Two functional single nucleotide polymorphisms (SNPs) in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C, lead to decreased enzyme activity and affect chemosensitivity of tumor cells. We investigated whether these MTHFR SNPs were associated with breast cancer survival in African-A...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-257
更新日期：2006-10-27 00:00:00
abstract：BACKGROUND:BRCA1 and BRCA2 mutations explain approximately one-fifth of the inherited susceptibility in high-risk Finnish hereditary breast and ovarian cancer (HBOC) families. EMSY is located in the breast cancer-associated chromosomal region 11q13. The EMSY gene encodes a BRCA2-interacting protein that has been implic...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3488-x
更新日期：2017-07-24 00:00:00
